Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 27, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Brain Metastases
Interventions
PROCEDURE

biological samples (blood test and lumbar puncture)

"On the day of excision of the cerebral metastasis, additional biological samples (blood test and lumbar puncture) will be taken in the operating room.~A biological sample of the tumor tissue (brain metastases of a solid cancer with contrast uptake of at least 1 cm accessible to surgical excision) will also be taken and preserved by freezing, in accordance with current practice and after obtaining their written agreement. .~Biological samples (liquid biopsies and tumour) from patients who have explicitly expressed their consent will be kept after the end of the research as part of a biobank in order to be able to carry out any additional analyses."

Trial Locations (1)

13009

RECRUITING

Hôpital Privé Clairval, Marseille

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT05848050 - Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases | Biotech Hunter | Biotech Hunter